Enhanced immune effects and protection conferred by simultaneously targeting GAPDH, SeM, and EAG of S. equi via TLR4.

This research examined a new multi-antigen treatment aimed at improving vaccines against strangles, a prevalent equine infectious disease. It found an increased immunity response and improved protection effect, suggesting its potential use as a more effective subunit vaccine candidate against S. equi infections.

Objective of the Research

• This study aimed to enhance the immune response and protection against Streptococcus equi subspecies equi, the bacteria responsible for strangles, a prevalent equine infectious disease. It questioned the effectiveness of existing vaccines and sought to optimize them by targeting three specific antigens.

Methods and Procedures

• The research team selected three target antigens: M-like protein, α2-macroglobulin and IgG-binding protein, and glyceraldehyde-3-phosphate dehydrogenase.
• The antigens were expressed, and mice were then immunized and challenged – the standard method for evaluating the immune response to a vaccine or treatment.

Findings and Results

• Post-immunization, the mice’s immune response was analyzed. The research team found high expression levels of T-cell receptor, Major Histocompatibility Complex I, and Toll-Like Receptor TLR-4. These are all key markers of an activated and effective immune response.
• The protection efficacy of the immunization was also evaluated, revealing notable improvements in mice that received the multi-antigen treatment.

Implications and Conclusions

• The study showed that by targeting these three proteins simultaneously, might lead to an improved immune response and protection against S. equi infection, providing a promising pathway for the development of a multicomponent subunit vaccine
• Its findings might not only improve the prevention and control of strangles but also contribute to reducing the economic losses associated with this widespread equine disease.